Poland· PL-100409878

Rosuvastatin MSN

A rosuvastatin product containing rosuvastatinum, registered in Poland by Vivanta Generics s.r.o.. The same ATC class is registered in 18 of our 19 countries.

ATC C10AA07

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about rosuvastatinumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Rosuvastatin is registered in 18 of 19 countries.

Countries holding a registration under ATC C10AA07 (rosuvastatin), each read from that country’s own register.

This record: Poland, from URPL (Poland)
11 of them publish a price we can compare per daily dose

Search rosuvastatin products by name

Rosuvastatin · ATC C10AA07

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of rosuvastatin costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $0.036 in United States to $0.73 in Switzerland — a ×20 gap.

5 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Rosuvastatin · price per daily dose (10 mg)

USD · FX 28 Sept 2026

CH Switzerland$0.73
ES Spain$0.39
IT Italy$0.26
FR France$0.17
US United States$0.036 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

URPL (Poland)

Active substance: Rosuvastatinum
Manufacturer: Vivanta Generics s.r.o.
Country: Poland (PL)
ATC code: C10AA07
ATC class: Rosuvastatin
Defined daily dose: 10 mg, O
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 15

gtin
05909991728687
gtin
05909991728694
gtin
05909991728700
gtin
05909991728717
gtin
05909991728724
gtin
05909991728731
gtin
05909991728748
gtin
05909991728755
gtin
05909991728762
gtin
05909991728779
gtin
05909991728786
gtin
05909991728649
gtin
05909991728656
gtin
05909991728663
gtin
05909991728670

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

689 interactions on record for rosuvastatin.

Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check rosuvastatin against other medicines How interaction checks work

Rosuvastatin · interactions on record

689 records

29 severe
200 moderate
20 minor
403 info

Most severe, free to view

ClofibrateC10AB01severe
GemfibrozilC10AB04severe
FenofibrateC10AB05severe
MipomersenC10AX11severe

37 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Rosuvastatin in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All rosuvastatin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Arosuva, Crestor
Belgium · Crestor, Rosuvastatin Ab
Bulgaria · Rossta, Rosuvastatin Viatris
Cyprus · Artepro, Celmantin
Czechia · Corvapro Neo, Mertenil
Germany · Crestor, Rosuvador
Denmark · Celmantin, Crestor
Estonia · Crestor, Rosucard
Spain · Abemax, Alcotina
Finland · Crestor, Rosuvastatin Actavis
France · Crestor, Rosuvastatine Almus
United Kingdom (Northern Ireland) · Crestor, Enebium
Greece · Celmantin, Crestilen
Croatia · Corvapro, Corvapro Neo
Hungary · Delipid, Ropuido
Ireland · Crestor, Rosuva
Iceland · Platorel, Rosuvastatin Actavis
Italy · Borghes, Colcardiol
Lithuania · Crestor, Rosuvacard
Luxembourg · Crestor, Rosuvastatin Micro Labs
Latvia · Crestor, Rosuvacard
Malta · Celmantin, Corvapro Neo
Netherlands · Crestor, Provisacor
Norway · Crestor, Rosuvastatin Glenmark
Portugal · Crestor, Crestor 10mg Ip
Romania · Crestor, Rosi
Sweden · Crestor, Rosuvastatin Glenmark
Slovenia · Celmantin, Coupet
Slovakia · Provacor, Rosucard

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/ad5035fa-731f-4cc4-97d1-cbd3cae32225
GET /v1/drugs/ad5035fa-731f-4cc4-97d1-cbd3cae32225?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "10 mg",
  "packaging": "05909991728649 ¦ Rp ¦ 143114\n7 tabl.\n05909991728656 ¦ Rp ¦ 143115\n14 tabl.\n05909991728663 ¦ Rp ¦ 143116\n15 tabl.\n05909991728670 ¦ Rp ¦ 143117\n20 tabl.\n05909991728687 ¦ Rp ¦ 143118\n28 tabl.\n05909991728694 ¦ Rp ¦ 143119\n30 tabl.\n05909991728700 ¦ Rp ¦ 143120\n42 tabl.\n05909991728717 ¦ Rp ¦ 143121\n50 tabl.\n05909991728724 ¦ Rp ¦ 143122\n56 tabl.\n05909991728731 ¦ Rp ¦ 143123\n60 tabl.\n05909991728748 ¦ Rp ¦ 143124\n84 tabl.\n05909991728755 ¦ Rp ¦ 143125\n90 tabl. w blistrze\n05909991728762 ¦ Rp ¦ 143126\n98 tabl.\n05909991728779 ¦ Rp ¦ 143127\n100 tabl.\n05909991728786 ¦ Rp ¦ 143128\n90 tabl. w pojemniku",
  "substance": "Rosuvastatinum calicum 10.4 mg",
  "common_name": "Rosuvastatinum",
  "pl_product_id": "100409878",
  "pozwolenie_nr": "26832",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}

API reference MCP server Plans

See everything about rosuvastatin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console